Symeres’ daughter company Organix just got the keys to their new chemistry lab building, close to their current Headquarters in Woburn, just outside Boston MA.
This brand new 50,000 square ft (ca. 5000 m2) facility will be transformed in the coming months into state-of-the-art chemistry labs, with capacity for 100 chemists. It will give our US biotech and pharma clients significant further local support for synthetic chemistry, including in-depth knowledge in the field of lipids, and create a significant employment opportunity for talented organic chemists in the USA.
This expansion of Organix, following its acquisition earlier in 2022, is one part of the overall Symeres buy-and-build strategy in the USA and Europe, both in chemistry from the mg to kg scale and in integrated drug discovery.
“With our current facility reaching capacity, we’re excited that these new co-located laboratories will further our ambitions to be a major support for US life sciences companies, as their ‘lab next door,’” said Dr. Paul Blundell, President of Organix. “We’re also already working closely with our latest sister company Exemplify Biopharma, in Princeton NJ, for larger-scale chemistry, as well as with the broader Symeres organization.”
Keep an eye on our website or subscribe to our newsletter via the form below if you want to be updated on progress.